Jobless Claims Remain Near Historic Lows Pointing to Continued Labor Market Resilience
Strategy Pauses Bitcoin Accumulation to Prioritize 15B Bond Repurchase
US Stock Futures Bond Yields Decline as Putin Revises Nuclear Doctrine
UK Heatwave Drives Bank Holiday Travel Disruptions Potentially Impacting Retail and Transport Sectors
ADP Report Shows Private Payrolls Rose by 109000 in April Exceeding Estimates
US and Iran Nearing 60Day Ceasefire Extension with Strait of Hormuz Reopening Terms
Parsons Corporation PSN Q1 2026 Earnings EPS Surges Past Estimates as Operational Execution Drives Performance
AMT Q1 2026 Earnings EPS Surges Past Estimates with 1363 Beat
SNOW Q1 2026 Earnings EPS Surges Past Estimates as Profitability Gains Momentum
INOD Q1 2026 Earnings Massive EPS Beat Drives Investor Skepticism
EZRA Q1 2023 Earnings Massive EPS Surprise of 324 Against Negative Estimate Revenue Unreported
Blackstone Secured Lending Fund BXSL Q1 2026 Earnings EPS Beat Driven by Strong Investment Income and Portfolio Performance
XCHG Limited XCH Rebounds From Key Support Resistance Test Ahead
Blackrock MuniYield Quality Fund III Inc MYI Rallies 15 as YieldSeekers Return
Functional Brands Inc MEHA Slides 75 as Penny Stock Continues to Test Lower Support
Twist Bioscience TWST Holds Steady Near Midpoint as Key Levels Define Trading Range
CO2 Energy Transition Corp NOEM Holds Steady Near Trust Value as Support and Resistance Levels Defined
OPLN Q1 2026 Earnings EPS Beats Estimates by 124 Stock Rises
ICON Q4 2025 Earnings EPS Misses Estimates as Loss Widens Shares Rise 075
Value Line Inc Q1 2026 Earnings EPS of 069 Surprises Despite Revenue Silence
60 Degrees Pharmaceuticals Inc SXTP Q1 2026 Earnings EPS Misses Estimates No Revenue Yet
Dine Brands Global Inc DIN Q1 2026 Earnings Earnings Per Share Beat Estimates Amidst Operational Focus
Standard BioTools Q1 2026 Earnings Massive EPS Beat Fails to Lift Shares Amid Revenue Uncertainty
Trump Pressures Bank of America JPMorgan Over Alleged AntiConservative Practices
NCDL Q1 2026 Earnings EPS Miss Expected Stock Slips
Phio Pharmaceuticals Holds Steady Near Support Levels PHIO Stock Consolidates in Narrow Range